GIP and type 2 diabetes mellitus: Together, our findings support chronically elevating transgenic GIP expression exerts beneficial effects on a number of metabolic factors that are linked to the pathology of obesity and type 2 diabetes, and suggest that potential hypothalamic effects of transgenic GIP on food intake are worthy of further study.